In support of Gastroparesis Awareness Month, Healio recaps the latest research concerning GP including updates on clinical trials, the connection between GP and Ozempic (semaglutide, Novo Nordisk) and Mounjaro (tirzepatide, Eli Lilly), and more
Patients with a history of pancreatitis, diabetic ketoacidosis, type 1 diabetes, or severe kidney disease should avoid this combination without explicit multidisciplinary oversight
Clinical trial data showed similar weight loss outcomes between formulations when treatment was adhered to
Moreover, improvements in medication absorption and biocompatibility may offset the aforementioned drawbacks
Als Unterauftragsverarbeiter setzt iAdvize nach aktuellem Stand u.a
If you are ready to stop guessing and start a program tailored to your needs, the first step is simple